CURRENT MEDICAL RESEARCH AND OPINION, cilt.19, sa.3, ss.187-191, 2003 (SCI-Expanded)
Background: Elevated levels of C-reactive protein (CRP) are considered to be one of the indicators of poor prognosis in coronary artery disease (CAD). The aim of this study was to evaluate anti-inflammatory effects of atorvastatin in patients with CAD by measuring serum CRP levels.